| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/02/2006 | WO2006023441A2 Water-soluble conjugates and methods of preparation |
| 03/02/2006 | WO2006023412A2 Biomarkers for osteoarthritis |
| 03/02/2006 | WO2006023398A2 Modular isotope labelled mass spectrometry reagents and methods for quantitation of amino acids, peptides and proteins |
| 03/02/2006 | WO2006023383A1 Alleviation of non-specific binding in microarray assays |
| 03/02/2006 | WO2006023324A1 Protein microarrays |
| 03/02/2006 | WO2006023323A1 Microarrays utilizing hydrogels |
| 03/02/2006 | WO2006023272A1 2-polycyclic propynyl adenosine analogs having a2a agonist activity |
| 03/02/2006 | WO2006023123A2 Aptamer-functionalized electrochemical sensors and methods of fabricating and using the same |
| 03/02/2006 | WO2006022882A2 Canine pancreatic lipse |
| 03/02/2006 | WO2006022682A2 Method and compositions for treating diseases targeting cd49b |
| 03/02/2006 | WO2006022558A1 A method of assaying the antioxidant activity of oils. |
| 03/02/2006 | WO2006022457A1 Synoviolin transgenic flies |
| 03/02/2006 | WO2006022436A1 Method of examining hepatitis b/c virus-related disease by measuring thermocolloidal particle size distribution and examination apparatus |
| 03/02/2006 | WO2006022377A1 Method of selecting myocardial cells by using intracellular mitochondria as indication |
| 03/02/2006 | WO2006022361A1 Psf1 GENE-DEFICIENT ANIMAL AND METHOD OF USING THE SAME |
| 03/02/2006 | WO2006022344A1 Utilization of anti-mortalin 2 antibody and functional nucleic acid in treating cancer |
| 03/02/2006 | WO2006022277A1 Method for calculating dissociation constant in surface plasmon resonance analysis |
| 03/02/2006 | WO2006022226A1 Bioparameter output device and program |
| 03/02/2006 | WO2006022092A1 Probe for measuring cell potential |
| 03/02/2006 | WO2006021949A2 Simultant material and method for manufacture thereof |
| 03/02/2006 | WO2006021888A2 Dihydrofolate reductase inhibition by epigallocatechin gallate compounds |
| 03/02/2006 | WO2006021811A2 Treatment of posterior capsule opacification |
| 03/02/2006 | WO2006021810A1 Methods and compositions relating to alzheimer's disease |
| 03/02/2006 | WO2006021716A1 Device for detecting the binding of a target compound to a bait compound which is immobilised on a support and detection method |
| 03/02/2006 | WO2006021691A1 Method and device for biomass determination in a medium, in particular a medium containing biological cells, and measurement apparatus implementing said method |
| 03/02/2006 | WO2006021688A1 Method for analyzing food-based, cosmetic and/or hygiene industrial products, measuring interface for implementing said method and electronic system for using the interface |
| 03/02/2006 | WO2006021648A2 Multidisciplinary automatic analyser for in vitro diagnosis |
| 03/02/2006 | WO2006021553A1 Method for protein purification and labeling based on a chemoselective reaction |
| 03/02/2006 | WO2006021549A2 Method for the identification of atypical p-anca |
| 03/02/2006 | WO2006021451A2 Methods and compounds for treating diabetes |
| 03/02/2006 | WO2006021410A1 Microfluid system for the isolation of biological particles using immunomagnetic separation |
| 03/02/2006 | WO2006021347A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine receptor 3c (5-ht3c) |
| 03/02/2006 | WO2006021346A1 Diagnostics and therapeutics for diseases associated with alpha 2b-adrenoceptor (adra2b) |
| 03/02/2006 | WO2006021345A2 Diagnostics and therapeutics for diseases associated with adrenergic alpha-1b receptor (adra1b) |
| 03/02/2006 | WO2006021344A1 Diagnostics and therapeutics for diseases associated with alpha-1a adrenergic receptor (adra1a) |
| 03/02/2006 | WO2006021343A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine receptor 3a (5-ht3a) |
| 03/02/2006 | WO2006021214A2 A method and an apparatus for determining pregnancy of animals |
| 03/02/2006 | WO2006021210A2 Binding member towards pneumolysin |
| 03/02/2006 | WO2006007254A3 Biomarkers for wound healing |
| 03/02/2006 | WO2006004394A3 Method for detecting gluten |
| 03/02/2006 | WO2006000740A3 Assay and kits therefor |
| 03/02/2006 | WO2005121172A3 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation |
| 03/02/2006 | WO2005119564A3 Method for the use of density maps based on marker values in order to diagnose patients with diseases, particularly tumors |
| 03/02/2006 | WO2005117979A3 Use of il-17 in the treatment of fertility-related disorders |
| 03/02/2006 | WO2005115517A3 Methods of treating diabetes |
| 03/02/2006 | WO2005109004A3 Disease related protein aggregation |
| 03/02/2006 | WO2005108287A3 System and method for hydrocarbon processing |
| 03/02/2006 | WO2005103214A3 Perfume compositions |
| 03/02/2006 | WO2005101013A3 Materials and methods for screening modulators of neural regneration |
| 03/02/2006 | WO2005100991A3 Method for detecting dioxin-like compounds |
| 03/02/2006 | WO2005100990A3 Diagnostics and therapeutics for diseases associated with purinoceptor 2 type y (p2y2) |
| 03/02/2006 | WO2005095988A3 Selection of bacterial inner-membrane anchor polypeptides |
| 03/02/2006 | WO2005095964A3 Methods and compositions for the detection of cervical disease |
| 03/02/2006 | WO2005095638A3 A kit for measuring the thrombin generation in a sample of a patient’s blood or plasma |
| 03/02/2006 | WO2005093414A3 Assay devices utilizing chemichromic dyes |
| 03/02/2006 | WO2005092114A3 Compositions and methods for destruction of prion infectious proteins |
| 03/02/2006 | WO2005090404A3 Compositions and methods for detecting cyclic analogs of human parathyroid hormone (hpth) |
| 03/02/2006 | WO2005089735A3 Compositions and methods for treating lung cancer |
| 03/02/2006 | WO2005079243A3 Compositions and methods for identifying sperm for forensic applications |
| 03/02/2006 | WO2005075987A3 Diagnostics and therapeutics for diseases associated with human metabotropic glutamate receptor 1 (mglur1) |
| 03/02/2006 | WO2005072388A3 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone |
| 03/02/2006 | WO2005071414A3 Kit for immobilizing organic substance, organic substance-immobilized structure, and manufacturing methods therefor |
| 03/02/2006 | WO2005069187A3 Methods and system for the identification and characterization of peptides and their functional relationships by use of measures of correlation |
| 03/02/2006 | WO2005069009A3 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN STEROID PROGESTIN RECEPTOR BETA (mSR-BETA) |
| 03/02/2006 | WO2005058142A3 Diabetes diagnostic |
| 03/02/2006 | WO2005050206A3 Competitive immunoassay |
| 03/02/2006 | WO2005046667A3 System a transport inhibitors for treating or preventing neuropsychiatric disorders |
| 03/02/2006 | WO2005037210A3 Photocleavable isotope-coded affinity tags |
| 03/02/2006 | WO2005033895A3 Method and apparatus for discovering patterns in binary or categorical data |
| 03/02/2006 | WO2005032487A3 Angiotensin-converting enzyme-2 as a receptor for the sars coronavirus |
| 03/02/2006 | WO2005029042A3 Fabrication and packaging of suspended microchannel detectors |
| 03/02/2006 | WO2005014781A3 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |
| 03/02/2006 | WO2004096148A3 Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof |
| 03/02/2006 | WO2004094465A3 Synthetic molecules that mimic chemokines |
| 03/02/2006 | WO2004083447A3 Mbcats as modifiers of the beta-catenin pathway and methods of use |
| 03/02/2006 | WO2004076678A3 Translucent solid matrix assay device for microarray analysis |
| 03/02/2006 | WO2004066933A3 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 03/02/2006 | WO2004066808A3 Glycan markers for diagnosing and monitoring disease |
| 03/02/2006 | WO2004061086A3 Flj10607 as modifier of the axin pathway and methods of use |
| 03/02/2006 | WO2004051561A3 Systems and methods for sequence comparison |
| 03/02/2006 | WO2004039334A3 CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING |
| 03/02/2006 | WO2004017039A3 Methods for identifying a prospective binding site on a target molecule and for characterizing a site on a target molecule |
| 03/02/2006 | WO2004016758A3 Brain endothelial cell expression patterns |
| 03/02/2006 | WO2003070879A3 Cyclin dependent kinase 5 phosphorylation of disabled 1 protein |
| 03/02/2006 | WO2002072769A3 Human serpin polypeptides |
| 03/02/2006 | US20060047616 System and method for biological data analysis using a bayesian network combined with a support vector machine |
| 03/02/2006 | US20060047440 Apparatus, method, and computer product for supporting estimation of metabolism |
| 03/02/2006 | US20060047432 Method of determining multiphase flow parameters of a porous medium Taking account of the local heterogeneity |
| 03/02/2006 | US20060046963 Compound for inhibiting the influx of polymorphonuclear leukocytes (PMNs) in a tissue, its selection, pharmaceutical compositions and use |
| 03/02/2006 | US20060046313 Cellular analysis using Raman surface scanning |
| 03/02/2006 | US20060046312 and a wavelength shift detector; coated with a biological or recognition element which binds preferentially with a target analyte; recognition element and the target analyte adhere to the sidewall surface of laser and increase the effective diameter of the laser which shifts output wavelength |
| 03/02/2006 | US20060046311 Biomolecule analysis using Raman surface scanning |
| 03/02/2006 | US20060046310 Amplification method for solid phase immunoassays |
| 03/02/2006 | US20060046305 Method and apparatus for detecting analyte with filter |
| 03/02/2006 | US20060046304 Thermal energy manipulation; efficient thermal cycling of a fluid in a retainment region of a fluid processing device while maintaining an adjacent second retainment region at a different temperature |
| 03/02/2006 | US20060046303 Method of eliminating phosphate group of peptide and method of analyzing peptide |
| 03/02/2006 | US20060046302 Using solution phase chemiluminescence detection for the quantification |
| 03/02/2006 | US20060046301 Lipid reference standard composed of a pure constituent of known value and a stabilizing amount of an antioxidant such as 3,3'-thiodipropionic acid and having a pH of 6.5 to 8.0; for calibration verification, linearity, and quality control of lipid and lipoprotein detectors |
| 03/02/2006 | US20060046297 Performs relative permeability profiling in lieu of hydraulic conductivity profiling, because it is faster and more easily automated while yielding information about likely stratigraphy and contaminant migration pathways; uses a direct push probe |
| 03/02/2006 | US20060046296 Method of correction at sample analysis, analyzer and analytical equipment |